Kiora Pharmaceuticals Inc. (KPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,394 | 167 | 501 | 1,973 | N/A |
| Receivables | 933 | 25 | 35 | 39 | N/A |
| TOTAL | $9,449 | $219 | $559 | $2,053 | $N/A |
| Non-Current Assets | |||||
| PPE Net | N/A | 1 | 3 | 8 | N/A |
| Other Non-Current Assets | 59 | 1,186 | 131 | 281 | 0 |
| TOTAL | $59 | $1,188 | $134 | $290 | $N/A |
| Total Assets | $9,508 | $1,407 | $692 | $2,343 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 418 | 602 | 55 | 149 | 0 |
| Accrued Expenses | 1,096 | 913 | 489 | 564 | N/A |
| Other current liabilities | N/A | 303 | N/A | N/A | N/A |
| TOTAL | $3,421 | $5,024 | $2,571 | $747 | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,908 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | -5 | -223 | -197 | -226 | 0 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,421 | $5,024 | $2,571 | $747 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2 | N/A | N/A | N/A | N/A |
| Common Shares | 77 | 2 | 2 | 2 | N/A |
| Retained earnings | -65,255 | -56,862 | -55,088 | -51,209 | N/A |
| Other shareholders' equity | 56 | 43,187 | 42,823 | 42,603 | 0 |
| TOTAL | $6,087 | $-3,618 | $-1,879 | $1,596 | $N/A |
| Total Liabilities And Equity | $9,508 | $1,407 | $692 | $2,343 | $0 |